Gastrin Tetrapeptide
CAS: 1947-37-1
Ref. 3D-FG108885
| 1g | 1,436.00 € | ||
| 50mg | 181.00 € | ||
| 100mg | 318.00 € | ||
| 250mg | 532.00 € | ||
| 500mg | 877.00 € |
Product Information
- H-Trp-Met-Asp-Phe-NH2 H-WMDF-NH2
- Ccris 3246
- Cholecystokinin tetrapeptide
- Gastrin tetrapeptide
- Gastrin tetrapeptide amide
- N-((Phenylmethoxy)carbonyl)-L-tryptophyl-L-methionyl-L-aspartyl-L-phenylalaninamide
- L-Phenylalaninamide, L-tryptophyl-L-methionyl-L-alpha-aspartyl-
- L-Phenylalaninamide, N-((phenylmethoxy)carbonyl)-L-tryptophyl-L-methionyl-L-aspartyl-
- L-Triptophyl-L-methyionyl-L-alpha-aspartyl-L-phenylalaninamide
- N-[(benzyloxy)carbonyl]tryptophylmethionyl-alpha-aspartylphenylalaninamide
- See more synonyms
- N-[(benzyloxy)carbonyl]-L-tryptophyl-L-methionyl-L-alpha-aspartyl-L-phenylalaninamide
- L-tryptophyl-L-methionyl-L-alpha-aspartyl-L-phenylalaninamide
Gastrin tetrapeptide is a pharmacological treatment for clinical relevance. It has been shown to be an irreversible inhibitor of the histamine H2-receptor. Activated gastrin tetrapeptide has been shown to inhibit the activity of 5-hydroxytryptamine (5-HT) receptors and κ-opioid receptors in vitro, and studies have shown that it decreases glutamate release from nerve cells, which may contribute to its antiemetic properties. Gastrin tetrapeptide has also been shown to have a physiological effect on humans, with decreased 5-HT concentrations and increased gastric pH levels being observed. This peptide is used in the treatment of infectious diseases such as malaria, which causes vomiting and diarrhea.
Chemical properties
Technical inquiry about: 3D-FG108885 Gastrin Tetrapeptide
If you want to request a quotation or place an order, please instead add the desired products to your cart and then request a quotation or order from the cart. It is faster, cheaper, and you will be able to benefit from the available discounts and other advantages.
